Featured Question

Please provide a concise summary of the treatment options for LGS: Do they vary according to patient’s age or other factors, and are there any medications or treatment changes recommended when a patient with LGS is transitioned from pediatric to adult care?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

10-17-2014

Challenging Cases in Advanced Prostate Cancer: Expert Guidance on Selection and Sequencing of the Latest Therapies

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

10-02-2014

Latest Imaging Tools for Assessing the Disease Course of Patients With Multiple Sclerosis

Course Director
Matilde Inglese, MD, PhD
Icahn School of Medicine at
Mount Sinai
New York, New York

09-19-2014

Assessing the Evolving Therapeutic Landscape in Advanced Prostate Cancer: Where Do We Stand?

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

09-04-2014

Practical Considerations in the Management of Patients With Ulcerative Colitis

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

09-02-2014

Current and Emerging Imaging Techniques in Multiple Sclerosis: Where Are We Now and Where Are We Going?

Course Director
Robert Naismith, MD
Washington University
School of Medicine
St. Louis, Missouri

08-04-2014

The Expanding Role of Biologic Therapies for Ulcerative Colitis: Assessing the State of the Science and Implications for Practice

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

07-11-2014

Practical Considerations for the Management of Alzheimer’s Disease: Tools for Recognition of Early Disease and Nuances of Individualized Treatment Selection

Course Director
Anton P. Porsteinsson, MD
University of Rochester
School of Medicine and Dentistry
Rochester, New York

07-04-2014

Q&A: Assessing the Evolving Role of Angiogenesis-Targeting Agents in the Treatment of Gynecologic Cancers

Course Director
Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University School of Medicine
Philadelphia, Pennsylvania

03-15-2013

Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York